Paracrine Control of Α-Cell Glucagon Exocytosis Is Compromised in Human Type-2 Diabetes

Nature Communications - United Kingdom
doi 10.1038/s41467-020-15717-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, Α Cell Hyperplasia, and Islet Cell Tumor

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2009English

Phagocytosis via Complement or Fc-Gamma Receptors Is Compromised in Monocytes From Type 2 Diabetes Patients With Chronic Hyperglycemia

PLoS ONE
Multidisciplinary
2014English

In Vivo Inhibition of Glucagon Secretion by Paracrine Beta Cell Activity in Man.

Journal of Clinical Investigation
Medicine
1981English

Islet Cell Failure in Type 2 Diabetes

Journal of Clinical Investigation
Medicine
2006English

Is Particle Pollution in Outdoor Air Associated With Metabolic Control in Type 2 Diabetes?

PLoS ONE
Multidisciplinary
2014English

Glycemic Control in Type 2 Diabetes Mellitus Patients

Chattagram Maa-O-Shishu Hospital Medical College Journal
2012English

A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy